{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:16:56Z","timestamp":1772889416427,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.brainres.2005.03.018","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T11:40:57Z","timestamp":1114083657000},"page":"142-149","source":"Crossref","is-referenced-by-count":47,"title":["Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug\u2013drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs"],"prefix":"10.1016","volume":"1045","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Faghih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon","family":"Cowart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim A.","family":"Esbenshade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Art A.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne E.","family":"Rueter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2005.03.018_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(85)90233-7","article-title":"Autoregulation of histamine release in brain by presynaptic H3-receptors","volume":"15","author":"Arrang","year":"1985","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2005.03.018_bib2","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1007\/s000110050406","article-title":"Acetylcholine release from hippocampus of freely moving rats is modulated by thioperamide and cimetidine","volume":"48","author":"Bacciottini","year":"1999","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.brainres.2005.03.018_bib3","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1476-5381.1996.tb16086.x","article-title":"Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats","volume":"119","author":"Blandina","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2005.03.018_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1996.tb05942.x","article-title":"The role of cognition in the risk-benefit and safety analysis of antipsychotic medication","volume":"389","author":"Borison","year":"1996","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.brainres.2005.03.018_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbr.2003.11.001","article-title":"Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan","volume":"153","author":"Browman","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2005.03.018_bib6","first-page":"1073","article-title":"New antipsychotic agents for schizophrenia: pharmacokinetics and metabolism update","volume":"3","author":"Caccia","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.brainres.2005.03.018_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90498-7","article-title":"Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse","volume":"259","author":"Clapham","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2005.03.018_bib8","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1007\/s00011-003-0333-2","article-title":"The medicinal chemistry of novel H(3) antagonists","volume":"53","author":"Cowart","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.brainres.2005.03.018_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bmcl.2003.11.032","article-title":"A new class of potent non-imidazole H(3) antagonists: 2-aminoethylbenzofurans","volume":"14","author":"Cowart","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.brainres.2005.03.018_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1006938908284","article-title":"Metabolism, pharmacogenetics, and metabolic drug\u2013drug interactions of antipsychotic drugs","volume":"19","author":"Fang","year":"1999","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2005.03.018_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00402761","article-title":"Lesions in corpus striatum and cortex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour","volume":"18","author":"Fog","year":"1970","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.brainres.2005.03.018_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00379-5","article-title":"Effects of histamine H(3) receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup","volume":"131","author":"Fox","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2005.03.018_bib13","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1007\/s000110300041","article-title":"Identification of novel H3 receptor (H3R) antagonists with cognition enhancing properties in rats","volume":"52","author":"Fox","year":"2003","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.brainres.2005.03.018_bib14","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00011-003-0323-4","article-title":"Cognition enhancing effects of novel H3 receptor (H3R) antagonists in several animal models","volume":"53","author":"Fox","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.brainres.2005.03.018_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","article-title":"Pharmacological properties of ABT-239: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist","volume":"313","author":"Fox","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2005.03.018_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0006-8993(98)00597-6","article-title":"Unique activation of extracellular striato-pallidal neurotransmitters in rats following acute risperidone","volume":"801","author":"Grimm","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2005.03.018_bib17","series-title":"Milestones in Drug Discovery: Cognitive Enhancing Drugs","first-page":"97","article-title":"Cognition enhancing effects of drugs that target histamine receptors","author":"Hancock","year":"2004"},{"key":"10.1016\/j.brainres.2005.03.018_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0306-4522(02)00069-6","article-title":"Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens","volume":"112","author":"Hussain","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2005.03.018_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/dmd.31.3.243","article-title":"Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway","volume":"31","author":"Kalgutkar","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.brainres.2005.03.018_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00428402","article-title":"Evidence for a cholinergic role in haloperidol-induced catalepsy","volume":"85","author":"Klemm","year":"1985","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.brainres.2005.03.018_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00248371","article-title":"Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex","volume":"70","author":"Klockgether","year":"1988","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.brainres.2005.03.018_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00213-003-1431-0","article-title":"H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization","volume":"167","author":"Komater","year":"2003","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.brainres.2005.03.018_bib23","first-page":"658","article-title":"Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist","volume":"287","author":"Ligneau","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2005.03.018_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002130050265","article-title":"8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A\/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release","volume":"131","author":"Lucas","year":"1997","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.brainres.2005.03.018_bib25","first-page":"590","article-title":"Atypical neuroleptics enhance histamine turnover in brain via 5-hydroxytryptamine2A receptor blockade","volume":"288","author":"Morisset","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2005.03.018_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.npp.1300380","article-title":"Histamine H3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release","volume":"29","author":"Munzar","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2005.03.018_bib27","series-title":"Neuroscience Conference, Program No. 956.7","article-title":"Combined histamine H3 and dopamine D2 receptor antagonism in treatment of schizophrenia","author":"Olsen","year":"2003"},{"key":"10.1016\/j.brainres.2005.03.018_bib28","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.22-16-07272.2002","article-title":"Ciproxifan, a histamine H3-receptor antagonist\/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat","volume":"22","author":"Pillot","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2005.03.018_bib29","series-title":"Clinical Pharmacokinetics Concepts and Applications","author":"Rowland","year":"1995"},{"key":"10.1016\/j.brainres.2005.03.018_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01244933","article-title":"Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors","volume":"93","author":"Schlicker","year":"1993","journal-title":"J. Neural Transm.: Gen. Sect."},{"key":"10.1016\/j.brainres.2005.03.018_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0361-9230(94)90092-2","article-title":"Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats","volume":"35","author":"Tucci","year":"1994","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2005.03.018_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000063794","article-title":"Coordination of histamine H3 receptor antagonists with human adrenal cytochrome P450 enzymes","volume":"66","author":"Yang","year":"2002","journal-title":"Pharmacology"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899305004397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899305004397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T04:39:55Z","timestamp":1550205595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899305004397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0006899305004397"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2005.03.018","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}